| Patents for C07H 19 - Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro derivatives thereof (20,008) |
|---|
| 05/12/1998 | US5750389 Purified saccharose-synthase, process for its production and its use |
| 05/12/1998 | US5750342 Contacting mixture of nucleic acids with target comprising blood cells, fibrin clots, carotid arteries, partitioning high affinity nucleic acids from remainder of mixture, amplifying to yield mixture enriched in high affinity nucleic acids |
| 05/12/1998 | CA1339861C 3roduction of 2',3' -dideoxy -2',3'-didehydronucleosides |
| 05/07/1998 | WO1998018430A2 P2y receptor antagonists |
| 05/07/1998 | WO1998018324A1 Induction of viral mutation by incorporation of miscoding ribonucleoside analogs into viral rna |
| 05/07/1998 | WO1998000173A3 Targeted drug delivery using sulfonamide derivatives |
| 05/07/1998 | CA2269213A1 Induction of viral mutation by incorporation of miscoding ribonucleoside analogs into viral rna |
| 05/07/1998 | CA2241687A1 P2y receptor antagonists |
| 05/06/1998 | EP0839828A1 Building blocks for DNA/PNA-Cooligomer |
| 05/06/1998 | EP0839814A2 Indolocarbazole derivatives and their use for the treatment of prostate gland disorders |
| 05/06/1998 | EP0839813A1 9-(2-deoxy-2-fluoro-4-thio-beta-d-arabinofuranosyl)purine derivatives |
| 05/06/1998 | EP0788364A4 Treatment of urogenital cancer with boron neutron capture therapy |
| 05/06/1998 | EP0742790A4 Substituted purines and oligonucleotide cross-linking |
| 05/06/1998 | EP0733214B1 Dense microsphere components derived from mammalian brain tissue and antibodies thereto |
| 05/06/1998 | EP0710242B1 Antiparasitic agents |
| 05/06/1998 | EP0682670B1 Deoxygenation of cis vicinal diols |
| 05/06/1998 | CN1181078A Non-nucleosidic coumarin derivatives as polynucleotide -cross -linking agents |
| 05/06/1998 | CN1181015A Reduction of infarct volume using citicoline |
| 05/05/1998 | US5747496 Inhibitors of platelet aggregation |
| 05/05/1998 | US5747474 Immunosuppression by administration of N6,N6 -disubstituted cAMP's, analogues thereof, and related nucleosides |
| 05/05/1998 | US5747473 L-nucleoside analogues and pharmaceutical compositions |
| 05/05/1998 | US5747472 Anticarcinogenic agents and antitumor agents |
| 05/05/1998 | US5747465 Sugar derivatives of macrolides |
| 05/05/1998 | US5747290 Process for the production of recombinant polypeptides |
| 05/05/1998 | CA2073567C Spicamycin derivatives and the use thereof |
| 05/05/1998 | CA1339854C Viral treatment system |
| 04/30/1998 | WO1998017325A2 Covalent polar lipid conjugates for targeting |
| 04/30/1998 | WO1998017281A1 MONOPHOSPHATE PRODRUGS OF β-L-FD4C AND β-L-FddC AS POTENT ANTIVIRAL AGENTS |
| 04/29/1998 | EP0837950A1 Primer walking cycle sequencing |
| 04/29/1998 | EP0783910A4 Process for the vacuum distillation of a liquid product, preferably crude petroleum, and a facility for carrying out the process |
| 04/29/1998 | CN1180359A Ascomycins |
| 04/29/1998 | CN1180356A Process for synthesis of nucleoside analogue |
| 04/28/1998 | US5744597 Stereoselective anion glycosylation process for preparing 2'-deoxy-2',2'-difluoronucleosides and 2'-deoxy-2'-fluoronucleosides |
| 04/28/1998 | US5744596 Antivirus agent |
| 04/28/1998 | US5744595 Propargyl modified nucleosides and nucleotides |
| 04/28/1998 | US5744592 Improving the bioavailability and absorption of a drug through the digestive tract by covalently bonding the drug and a 1-o-or-s-alkyl-sn-glycero-3-phosphate |
| 04/28/1998 | US5744465 Method of inhibiting a β-lactamase enzyme by administering novel 2-thiosubstituted carbapenems |
| 04/28/1998 | US5744461 Viricides |
| 04/28/1998 | US5744305 Arrays of materials attached to a substrate |
| 04/28/1998 | US5744101 Reactor system for synthesizing polymer sequences on substrate; solid phase synthesis |
| 04/23/1998 | WO1998016540A1 Improved coupling activators for oligonucleotide synthesis |
| 04/23/1998 | WO1998016539A1 Novel therapeutically active adenosine derivatives |
| 04/23/1998 | WO1998016186A2 Monocyclic l-nucleosides, analogs and uses thereof |
| 04/23/1998 | WO1998016184A2 Purine l-nucleosides, analogs and uses thereof |
| 04/23/1998 | CA2323791A1 Purine l-nucleosides, analogs and uses thereof |
| 04/23/1998 | CA2267279A1 Monocyclic l-nucleosides, analogs and uses thereof |
| 04/23/1998 | CA2266889A1 Purine l-nucleosides, analogs and uses thereof |
| 04/22/1998 | EP0836613A1 Water-soluble adenosine kinase inhibitors |
| 04/22/1998 | EP0836612A1 Novel synthons for stereoselective oligonucleotide synthesis |
| 04/22/1998 | CN1179722A Combination therapy for HIV infection using HIV protease inhibitor indinavir and reverse transcriptase inhibitor 3TC, optionally together with AZT, DDI or DDC |
| 04/16/1998 | WO1998015563A1 Tetraphosphonate bicyclic trisanhydrides |
| 04/16/1998 | CA2575919A1 Tetraphosphonate bicyclic trisanhydrides |
| 04/15/1998 | EP0835111A2 Method of dynamic retardation of cell cycle kinetics to potentiate cell damage |
| 04/15/1998 | EP0699204B1 Use of indolocarbazole derivatives to treat a pathological condition of the prostate |
| 04/14/1998 | US5739314 One-step selective alkylation of an anhydropyrimidine with magnesium alkoxide in the corresponding alcohol; efficiency |
| 04/14/1998 | US5739300 Antiadhesive piperidine-and pyrrolidinecarboxylic acids |
| 04/14/1998 | US5739120 Treatment of viral infections by administration of α- 1-(3-alkylthio-3-deoxy-2-O-acylglyceryl)!-ω 5'-(9-arabinosylpurinyl)! diphosphates or purine isosters thereof |
| 04/08/1998 | EP0834576A2 Methods using nucleic acid hybridization patterns on a matrix of oligonucleotides |
| 04/08/1998 | EP0834575A2 Methods using target nucleic acid hybridization patterns on a matrix of oligonucleotides |
| 04/08/1998 | EP0680488B1 2,6-diaminopurine derivatives |
| 04/08/1998 | CN1178535A Therapeutic compound-fatty acid conjugates |
| 04/07/1998 | US5736554 Treating and/or preventing cardiovascular disorders |
| 04/07/1998 | US5736531 Compositions of chemotherapeutic agent or antiviral agent with acylated pyrimidine nucleosides |
| 04/07/1998 | US5736530 Mono- or divalent trace element metal salt of 5'-guanylic acid; anxiolytic agents, cognition activators, vasodilators, nutrients |
| 04/07/1998 | US5736528 N6 -(epoxynorborn-2-yl) adenosines as A1 adenosine receptor agonists |
| 04/07/1998 | US5736525 Used for treatemnt of acquired immuno deficiency syndrome with anti-aids drugs selected from 3'-azido-3'-deoxythymidine(azt), dideoxyinosine(ddi), or dideoxycytidine(ddc) |
| 04/04/1998 | CA2217377A1 Building blocks for dna/pna co-oligomers |
| 04/02/1998 | WO1998013368A1 New pharmaceutically active compounds |
| 04/02/1998 | WO1998013358A1 O2-arylated or o2-glycosylated 1-substituted diazen-1-ium-1,2-diolates and o2-substituted 1-[(2-carboxylato)pyrrolidin-1-yl]diazen-1-ium-1,2-diolates |
| 04/02/1998 | WO1998013007A2 Methods and compositions for lipidization of hydrophilic molecules |
| 04/02/1998 | CA2705474A1 O2-glycosylated 1-substituted diazen-1-ium-1,2-diolates |
| 04/02/1998 | CA2267179A1 Methods and compositions for lipidization of hydrophilic molecules |
| 04/02/1998 | CA2265854A1 New pharmaceutically active compounds |
| 04/01/1998 | EP0832299A1 Use of nucleic acid ligands in flow cytometry |
| 04/01/1998 | EP0832291A1 Enzyme linked oligonucleotide assays (elonas) |
| 04/01/1998 | EP0832286A1 Modified nucleotides for nucleic acid labeling |
| 04/01/1998 | EP0832092A1 Orally active adenosine kinase inhibitors |
| 04/01/1998 | EP0832091A1 C-4' modified adenosine kinase inhibitors |
| 04/01/1998 | EP0831855A1 Nucleotide analogues for topical treatment of proliferative disease of the skin |
| 04/01/1998 | EP0831852A1 Nucleosides with anti-hepatitis b virus activity |
| 04/01/1998 | EP0831849A1 Methods of reducing toxicity of chemotherapeutic and antiviral agents with acylated pyrimidine nucleosides |
| 04/01/1998 | EP0831794A1 Acyclovir derivatives for topical use |
| 04/01/1998 | EP0831777A1 Dinucleotides useful for the treatment of lung disease |
| 04/01/1998 | EP0677054B1 New antiparasitic agents related to the milbemycins and avermectins |
| 03/31/1998 | US5734049 Processes for preparing intermediates of inhibitors of enkephalinase and angiotensin converting enzyme and intermediates thereof |
| 03/31/1998 | US5734042 Process for the production of asymmetrical phosphoric acid diesters |
| 03/31/1998 | US5734041 Preparation of chiral phosphorothioate oligomers |
| 03/31/1998 | US5734034 Nucleic acid ligand inhibitors of human neutrophil elastase |
| 03/31/1998 | US5733890 Adenylate analogs as potent anti-herpes virus agents |
| 03/31/1998 | US5733887 Related to avermectins and milbemycins |
| 03/31/1998 | CA2133961C A process for the preparation of ribonucleotide reductase inhibitors |
| 03/26/1998 | WO1998006835A3 Modifying insect cell gylcosylation pathways with baculovirus expression vectors |
| 03/24/1998 | US5731429 Cac -methylphosphonamidites and methods for preparing methylphosphonates |
| 03/24/1998 | US5731424 High affinity TGFβ nucleic acid ligands and inhibitors |
| 03/24/1998 | US5731320 Macrocyclic amide and urea immunomodulators |
| 03/24/1998 | US5731296 Selective vasodilation by continuous adenosine infusion |
| 03/24/1998 | US5731295 Method of reducing stromelysin RNA via ribozymes |
| 03/24/1998 | US5731144 High affinity TGFβ nucleic acid ligands |
| 03/19/1998 | WO1998011123A1 Carbamate-derivatized nucleosides and oligonucleosides |
| 03/19/1998 | WO1998011122A1 Selenium and s-adenosylmethionine nutritive composition |